<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36741670</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Role of Polymerase Chain Reaction-Based Diagnosis of Respiratory Viruses in Febrile Neutropenic Patients.</ArticleTitle><Pagination><StartPage>e33314</StartPage><MedlinePgn>e33314</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33314</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.33314</ELocationID><Abstract><AbstractText>Background Neutropenic patients are commonly affected by respiratory infections, whereas respiratory viral infections causing high morbidity and mortality are routinely diagnosed in developing countries like India. Our study aimed to investigate the prevalence of respiratory viral infections in pediatric cancer patients with febrile neutropenia.  Methods This prospective study was performed on 45 neutropenia patients with hematological malignancies. Nasal swabs were collected and analyzed by real-time multiplex polymerase chain reaction (PCR), covering the following viruses: influenza A virus, influenza B virus, human parainfluenza virus (subtypes 1-4), human respiratory syncytial virus A and B, enterovirus, human-coronavirus (HCoV: HKU1, NL63, 229E, and OC43), human bocavirus, adenovirus, human rhinovirus, human-metapneumovirus A and B, human paraechovirus, and a bacterium <i>Mycoplasma pneumoniae</i>. Patients enrolled in the study since the COVID-19 pandemic was also detected for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Results Of the 45 cases included in our study, 26 cases showed the presence of at least one positivity by PCR (57.7%): 23 patients had monoinfection with only one virus, two patients were found positive for coinfection with two viruses, and one patient was found positive for three viruses. The most detected viruses were human rhinovirus (26.9%, n=7) and coronavirus 19 (19.2%, n=5). A total of 11.5% of the patients had multiple viral infections. About 19 (42.2%) of the patients enrolled in our study had no viral pathogen detected. Conclusion We found that respiratory viruses contribute significantly to the development of neutropenic fever, as evidenced by the results of our prospective study. Individualizing infection treatment can reduce antibiotic use in immunocompromised patients. Thus, routine screening for viremia may be warranted in this clinical setting.</AbstractText><CopyrightInformation>Copyright © 2023, Madhuravasal Krishnan et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Madhuravasal Krishnan</LastName><ForeName>Janani</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Microbiology, Medical Research Foundation, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaraman</LastName><ForeName>Dhaarani</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kancharla</LastName><ForeName>Adarsh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangam</LastName><ForeName>Aishwarya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Microbiology, Medical Research Foundation, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatramanan</LastName><ForeName>Padmasani</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Julius Xavier</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">febrile neutropenia</Keyword><Keyword MajorTopicYN="N">polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">respiratory infection</Keyword><Keyword MajorTopicYN="N">respiratory viruses</Keyword><Keyword MajorTopicYN="N">sars-cov-2 (severe acute respiratory syndrome coronavirus -2)</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36741670</ArticleId><ArticleId IdType="pmc">PMC9894571</ArticleId><ArticleId IdType="doi">10.7759/cureus.33314</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clin Infect Dis. 2011;52:56–93.</Citation><ArticleIdList><ArticleId IdType="pubmed">21258094</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Sipsas NV, Bodey GP, Kontoyiannis DP. Cancer. 2005;103:1103–1113.</Citation><ArticleIdList><ArticleId IdType="pubmed">15666328</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Castagnola E, Fontana V, Caviglia I, et al. Clin Infect Dis. 2007;45:1296–1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">17968824</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory viruses, a common microbiological finding in neutropenic children with fever. Lindblom A, Bhadri V, Söderhäll S, et al. J Clin Virol. 2010;47:234–237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108298</ArticleId><ArticleId IdType="pubmed">20056482</ArticleId></ArticleIdList></Reference><Reference><Citation>Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia. Torres JP, Labraña Y, Ibañez C, et al. Pediatr Infect Dis J. 2012;31:889–893.</Citation><ArticleIdList><ArticleId IdType="pubmed">22565292</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasopharyngeal detection of respiratory viruses in febrile neutropenic children. Suryadevara M, Tabarani CM, Bartholoma N, et al. Clin Pediatr. 2012;51:1164–1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">22893186</ArticleId></ArticleIdList></Reference><Reference><Citation>Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. Lehrnbecher T, Robinson P, Fisher B, et al. J Clin Oncol. 2012;30:4427.</Citation><ArticleIdList><ArticleId IdType="pubmed">28459614</ArticleId></ArticleIdList></Reference><Reference><Citation>Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia. Santolaya ME, Alvarez AM, Avilés CL, et al. Pediatr Infect Dis J. 2013;32:1318–1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">24569305</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial. Santolaya ME, Alvarez AM, Acuña M, et al. Clin Microbiol Infect. 2017;23:173–178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129180</ArticleId><ArticleId IdType="pubmed">27856269</ArticleId></ArticleIdList></Reference><Reference><Citation>European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Averbuch D, Orasch C, Cordonnier C, et al. Haematologica. 2013;98:1826–1835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3856957</ArticleId><ArticleId IdType="pubmed">24323983</ArticleId></ArticleIdList></Reference><Reference><Citation>Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer. El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L. Pediatr Blood Cancer. 2011;57:283–288.</Citation><ArticleIdList><ArticleId IdType="pubmed">21671364</ArticleId></ArticleIdList></Reference><Reference><Citation>Invasive fungal infections in paediatric acute myeloid leukaemia. Johnston DL, Lewis V, Yanofsky R, et al. Mycoses. 2013;56:482–487.</Citation><ArticleIdList><ArticleId IdType="pubmed">23437849</ArticleId></ArticleIdList></Reference><Reference><Citation>The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. J Pediatr Hematol Oncol. 2008;30:886–890.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131772</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. Freymuth F, Vabret A, Cuvillon‐Nimal D, et al. J Med Virol. 2006;78:1498–1504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159369</ArticleId><ArticleId IdType="pubmed">16998894</ArticleId></ArticleIdList></Reference><Reference><Citation>Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms. van de Pol AC, van Loon AM, Wolfs TF, et al. J Clin Microbiol. 2007;45:2260–2262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1932984</ArticleId><ArticleId IdType="pubmed">17507513</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. van Elden LJ, van Kraaij MG, Nijhuis M, Hendriksen KA, Dekker AW, Rozenberg-Arska M, van Loon AM. Clin Infect Dis. 2002;34:177–183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109912</ArticleId><ArticleId IdType="pubmed">11740705</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Chemaly RF, Shah DP, Boeckh MJ. Clin Infect Dis. 2014;59:344–351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303052</ArticleId><ArticleId IdType="pubmed">25352629</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza A/H1N1 in pediatric oncology patients. Dotan A, Ben-Shimol S, Fruchtman Y, et al. J Pediatr Hematol Oncol. 2014;36:271–274.</Citation><ArticleIdList><ArticleId IdType="pubmed">24136021</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathogenesis of bloodstream infection in children with blood cancer. Lv H, Ning B. Exp Ther Med. 2013;5:201–204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3524255</ArticleId><ArticleId IdType="pubmed">23251268</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children's Hospital, Alder Hey, UK. Paulus SC, van Saene HK, Hemsworth S, Hughes J, Ng A, Pizer BL. Eur J Cancer. 2005;41:2132–2140.</Citation><ArticleIdList><ArticleId IdType="pubmed">16129600</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Peck AJ, Englund JA, Kuypers J, et al. Blood. 2007;110:1681–1688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1975849</ArticleId><ArticleId IdType="pubmed">17502457</ArticleId></ArticleIdList></Reference><Reference><Citation>Prospective controlled survey of viral infections in children with acute lymphoblastic leukemia during chemotherapy. Möttönen M, Uhari M, Lanning M, et al. Cancer. 19951;75:1712–1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">8826932</ArticleId></ArticleIdList></Reference><Reference><Citation>Community respiratory viruses as a cause of lower respiratory tract infections following suppressive chemotherapy in cancer patients. El-Mahallawy HA, Ibrahim MH, Shalaby L, Kandil A. https://pubmed.ncbi.nlm.nih.gov/16508683/ J Egypt Natl Canc Inst. 2005;17:121–126.</Citation><ArticleIdList><ArticleId IdType="pubmed">16508683</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory virus infections in children with cancer or HIV infection. Mendoza Sánchez MC, Ruiz-Contreras J, Vivanco JL, et al. J Pediatr Hematol Oncol. 2006;28:154–159.</Citation><ArticleIdList><ArticleId IdType="pubmed">16679938</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory virus infections during anticancer treatment in children. Arola M, Ruuskanen O, Ziegler T, Salmi TT. Pediatr Infect Dis J. 1995;14:690–694.</Citation><ArticleIdList><ArticleId IdType="pubmed">8532427</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory viral infections in children with leukemia. Koskenvuo M, Möttönen M, Rahiala J, et al. Pediatr Infect Dis J. 2008;27:974–980.</Citation><ArticleIdList><ArticleId IdType="pubmed">18833026</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory virus infections in children with acute lymphoblastic leukemia and febrile neutropenia: a prospective study. Täger FM, Zolezzi RP, Folatre BI, Navarrete CM, Rojas PJ. Rev Chilena Infectol. 2006;23:118–123.</Citation><ArticleIdList><ArticleId IdType="pubmed">16721444</ArticleId></ArticleIdList></Reference><Reference><Citation>Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Bredius RG, Templeton KE, Scheltinga SA, Claas EC, Kroes AC, Vossen JM. Pediatr Infect Dis J. 2004;23:518–522.</Citation><ArticleIdList><ArticleId IdType="pubmed">15194832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>